We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$663M
AUM Growth
-$835M
Cap. Flow
-$859M
Cap. Flow %
-129.52%
Top 10 Hldgs %
36.6%
Holding
684
New
251
Increased
107
Reduced
109
Closed
206

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Technology 17.81%
3 Consumer Discretionary 13.64%
4 Healthcare 9.49%
5 Financials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUOT
676
DELISTED
Quotient Technology Inc
QUOT
-15,577
Closed -$53.4K
AZRE
677
DELISTED
Azure Power Global Limited
AZRE
-52,017
Closed -$224K
KBAL
678
DELISTED
Kimball International
KBAL
-11,880
Closed -$77.2K
MYOV
679
DELISTED
Myovant Sciences Ltd.
MYOV
-7,977
Closed -$215K
CNCE
680
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
-83,993
Closed -$491K
LHCG
681
DELISTED
LHC Group LLC
LHCG
-3,483
Closed -$563K
SPNE
682
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
-11,200
Closed -$93.5K
AVEO
683
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-117,452
Closed -$1.76M
SBNY
684
DELISTED
Signature Bank
SBNY
-3,123
Closed -$360K

Similar funds

Caxton Associates (New York)'s Q1 2023 Portfolio in Review

As of Q1 2023, Caxton Associates (New York) held 684 positions worth $663M, down 56% from $1.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Caxton Associates (New York) withdrew a net $859M in Q1 2023, closing 206 positions and reducing 109 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 0.33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Caxton Associates (New York) opened a new position in Advanced Micro Devices worth $14.8M.

  • Caxton Associates (New York)'s largest Q1 2023 buy was Advanced Micro Devices: 151,421 shares worth $14.8M.
  • Caxton Associates (New York) added most to Freeport-McMoran in Q1 2023, an estimated $123M increase.
  • Caxton Associates (New York)'s biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $541M.
  • Caxton Associates (New York) fully exited iShares Biotechnology ETF in Q1 2023, selling an estimated $152M.
  • Caxton Associates (New York)'s ten largest holdings make up 37% of its $663M portfolio in Q1 2023.
  • Caxton Associates (New York) opened 251 new positions and closed 206 in Q1 2023.
  • Caxton Associates (New York)'s portfolio value fell 56% quarter-over-quarter to $663M.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.